Sarepta Therapeutics Community Letter: EMBARK Part 1 Topline Results

October 31, 2023

On October 30, 2023, Sarepta Therapeutics shared a Community Letter regarding topline results from the EMBARK study and more.

Please click here to view their Community Letter.

Experience the magic this summer!

How is the rare disease community accomplishing goals?

Tune in on February 29 to hear from our panel and moderators on how they are accomplishing goals and living life to the fullest!

Your gift helps Jett Foundation provide programming and opportunities, such as Camp Promise, to many families impacted by Duchenne muscular dystrophy each year.

Accessible Vehicle Fund Applications Open